MR IMAGING: ITS CURRENT AND POTENTIAL UTILITY IN THE DIAGNOSIS AND MANAGEMENT OF BREAST CANCER

2000 ◽  
Vol 8 (4) ◽  
pp. 715-728
Author(s):  
Nitin A. Kumar ◽  
Mitchell D. Schnall
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Potential Utility ◽  
Diagnosis And Management

MR Imaging with Histopathological Correlation in Vertebral Metastases of Breast Cancer

1992 ◽  
Vol 33 (3) ◽  
pp. 213-220 ◽  
Author(s):  
M. Petren-Mallmin ◽  
B. Nordstrom ◽  
I. Andreasson ◽  
R. Nyman ◽  
H. Jonsson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Vertebral Metastases ◽  
Histopathological Correlation

MR Imaging and Gene Therapy of Breast Cancer

2001 ◽  
Author(s):  
Min-Ying Su
Keyword(s):  
Breast Cancer ◽  
Gene Therapy ◽  
Mr Imaging

Molecular MR Imaging of CD44 in Breast Cancer with Hyaluronan-Based Contrast Agents

2009 ◽  
Author(s):  
Dmitri Artemov ◽  
Wenlian Zhu
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Contrast Agents

Value of Combined FDG PET and MR Imaging in the Evaluation of Suspected Recurrent Local-Regional Breast Cancer: Preliminary Experience

Radiology ◽  
1999 ◽  
Vol 210 (3) ◽  
pp. 807-814 ◽  
Author(s):  
Peter B. Hathaway ◽  
David A. Mankoff ◽  
Kenneth R. Maravilla ◽  
Mary M. Austin-Seymour ◽  
Georgiana K. Ellis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Fdg Pet

Flow cytometry: Potential utility in monitoring drug effects in breast cancer

1994 ◽  
Vol 32 (1) ◽  
pp. 57-65 ◽  
Author(s):  
Steven K. Koester ◽  
Juhani U. Maenpaa ◽  
Valerie J. Wiebe ◽  
W. Jeffrey Baker ◽  
Gregory T. Wurz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Flow Cytometry ◽  
Drug Effects ◽  
Potential Utility ◽  
Monitoring Drug

Distinct MR Imaging Features of Triple-Negative Breast Cancer with Brain Metastasis

2014 ◽  
Vol 25 (3) ◽  
pp. 474-481 ◽  
Author(s):  
Ren-Hua Yeh ◽  
Jyh-Cherng Yu ◽  
Chi-Hong Chu ◽  
Ching-Liang Ho ◽  
Hung-Wen Kao ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastasis ◽  
Mr Imaging ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Imaging Features

scholarly journals Axillary Web Syndrome in Breast Cancer: A Prevalent But Under-Recognized Postoperative Complication

Breast Care ◽  
2018 ◽  
Vol 13 (2) ◽  
pp. 129-132 ◽  
Author(s):  
Susan R. Harris
Keyword(s):  
Breast Cancer ◽  
Cohort Studies ◽  
Systematic Reviews ◽  
Nurse Practitioners ◽  
Case Reports ◽  
Case Series ◽  
Diagnosis And Management ◽  
Oncology Nurse ◽  
Management Interventions ◽  
Axillary Web Syndrome

The purpose of this review is to define axillary web syndrome (AWS) and describe its diagnosis and management. The following databases were searched through July 2017: PubMed, EMBASE (OvidSP), Cumulative Index for Nursing and Allied Health Literature, Physiotherapy Evidence Database, and Cochrane Database of Systematic Reviews. Search terms included ‘axillary web syndrome', ‘axillary cording', and ‘lymphatic cording'. 49 articles were identified; 8 did not relate to breast cancer, and 3 were not in English. Of the remaining articles, the majority were case reports, case series, or descriptive reviews. 2 systematic reviews were located as well as 1 randomized trial, 6 prospective cohort studies, and 2 retrospective cohort studies. Although a common sequela after axillary surgery for breast cancer staging, AWS has been poorly described in the medical literature as to the underlying pathophysiology, diagnosis, and management. Interventions range from patient education and simple reassurance that the syndrome will resolve spontaneously to active physical or manual therapies to maintain upper extremity range-of-motion, especially adequate motion for undergoing radiation therapy. Oncologists, breast surgeons, family physicians, and oncology nurse practitioners that work with patients with breast cancer should educate them about this prevalent complication and inform them preoperatively about what to anticipate.

How Does MR Imaging Help Care for My Breast Cancer Patient? Perspective of a Radiation Oncologist

2018 ◽  
Vol 26 (2) ◽  
pp. 295-302 ◽  
Author(s):  
Kaitlin M. Christopherson ◽  
Benjamin D. Smith
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Cancer Patient ◽  
Breast Cancer Patient ◽  
Patient Perspective ◽  
Radiation Oncologist

scholarly journals The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways

Oncotarget ◽  
2015 ◽  
Vol 6 (26) ◽  
pp. 21865-21877 ◽  
Author(s):  
Mounia Guerram ◽  
Zhen-Zhou Jiang ◽  
Bashir Alsiddig Yousef ◽  
Aida Mejda Hamdi ◽  
Hozeifa Mohamed Hassan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Signaling Pathways ◽  
Cancer Cell ◽  
Potential Utility ◽  
Metabolic Signaling ◽  
Cancer Induction ◽  
Cancer Cell Death

scholarly journals Diagnosis and management of vaginal dryness in menopause

2017 ◽  
Vol 24 (2) ◽  
pp. 70 ◽  
Author(s):  
Ali Baziad
Keyword(s):  
Breast Cancer ◽  
Urinary Tract ◽  
Sexual Intercourse ◽  
Vaginal Atrophy ◽  
Vaginal Dryness ◽  
Diagnosis And Management ◽  
Vaginal Cytology ◽  
Litmus Paper ◽  
Tract Infections ◽  
Urinary Problems

Objective: To review the diagnosis and management of vaginal dryness in menopausal womenMethods: Literature reviewResults: Lack of estrogen negatively impacts the vagina and the urinary tract. The vagina becomes dry (atrophic) and then causing pain during sexual intercourse. Vaginal atrophy can be diagnosed in the form of vaginal dryness (75%), painful sexual intercourse (38%), itching and discharge complaints. Sometimes the patient complained pain in urinating, frequent night urination, in-continence and recurrent urinary tract infections. Mucose of the cervix, vagina and vulva are thin. Vagina can bleed easi-ly. Diagnosis can also be made by measuring the pH of the vagina by using litmus paper and vaginal cytology. The management involves administration of local estrogen treatment using weak estrogen (E3) in the form of a cream. E3 cream does not need to be combined with progestogen. Other type of local hormonal therapy (TH) is DHEA cream. Giving a strong estrogen (E2) or equin estrogen should always be combined with progestogen to prevent endometrium hyperplasia, either administered locally or systemically. E3 cream is also safe in women with breast cancer who experienced vaginal atrophy.Conclusion: Lack of estrogen causes vaginal atrophy with symptoms of vaginal dryness. Vaginal atrophy also causes urinary problems. Diagnosis is based on symptoms, examination of vaginal pH and vaginal cytology. The management is by adminis-tering HT with estrogen. E3 creams is the most effective in relieving complaints caused by vaginal dryness and complaints caused by the bladder.

Sign in / Sign up

Export Citation Format

Share Document